Safe Orthopaedics Announces the 10,000th Surgical Kit Sold
16 April 2018 - 3:30PM
Business Wire
- Acceleration in sales across all
geographical regions
- New additions to the sales team
- 6,000 surgeries performed in France and
share of vertebral fracture market doubled
Regulatory News:
SAFE ORTHOPAEDICS (Paris:SAFOR) (FR0012452746 – SAFOR), a
company specialized in the design and marketing of single-use
implants and instruments improving the minimally invasive treatment
of spinal fracture conditions, is today announcing that it has now
sold more than 10,000 surgical kits worldwide since they were first
launched. Safe Orthopaedics’ sterile kits all include
single-use instruments and at least one vertebral implant.
In another landmark achievement, the number of surgeries
performed using Safe Orthopaedics’ kits in France has risen above
6,000, after an acceleration in 2017. The factors driving this
substantial increase include additions to the sales team, which has
expanded from four to seven staff, and the more rapid adoption of
its SteriSpine PS technology for the treatment of all types of
fracture (accidental, metastatic and osteoporotic). In 2017, the
company doubled its market share in this core segment in France to
reach 8%.
“Selling our 10,000th surgical kit represents a major milestone
for Safe Orthopaedics, and we wanted to take the opportunity to
thank all the surgeons who use our products for their trust and
continuing loyalty to our technology. We would also like to thank
our shareholders—without them, we would not have been able to
develop our concept into the internationally adopted product it is
today”, said Pierre Dumouchel, Chief Executive Officer and
Co-founder of Safe Orthopaedics, adding: “We are delighted that
more than 10,000 patients have been able to reap the benefit of our
safer technology, and we are confident that we will be able to
replicate in Germany our fine accomplishments in France and
identify other international development opportunities while
continuing to expand our sales teams.”
Financial Agenda:
- Full-year 2017 results and
first-quarter 2018 revenues on Friday April 27, 2018 (before market
open)
- General Shareholders’ Meeting, Thursday
June 28, 2018
About Safe OrthopaedicsFounded in 2010, Safe Orthopaedics
is a French medical technology company that offers the safest
technologies to treat spinal fracture. Delivered sterile, all
implants and respective disposable instrumentation are available to
the surgeon at any time, any place. These technologies enable
minimally invasive approaches, reducing risks of cross
contamination and infection in the interest of the patient.
Protected by 17 patent families, the SteriSpine™ Kits are CE marked
and FDA cleared. The company is based at Eragny-Sur-Oise (France),
and has 36 employees.
For more information, visit: www.SafeOrtho.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180415005097/en/
Safe OrthopaedicsFrançois-Henri Reynaud, +33 (0)1 34 21
50 00CFOinvestors@safeorthopaedics.comorInvestor RelationsNewCapJulien Perez /
Valentine Brouchot, +33 (0)1 44 71 94
94SafeOrtho@newcap.euorPress
RelationsUlysse CommunicationBruno Arabian, 06 87 88
47 26barabian@ulysse-communication.comorNicolas Daniels, 06 63 66
59 22ndaniels@ulysse-communication.com